Patents by Inventor Fujun Li
Fujun Li has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20250066220Abstract: The present invention belongs to the technical field in sodium ion battery, which includes material synthesis, and discloses a high-entropy cathode material with a chemical formula of Na1-xKxNiyFezMndTimZn1-y-z-d-mO2, wherein 0<x?0.1, 0<y, z, d, and m?1. Its crystallographic structure is a hexagonal system with a space group of R-3m, where the arrangement subsequence of transition metal layers is ABCABC. Ni, Fe, Zn, Mn and Ti elements occupy in a transition metal layer and are arranged in a disordered subsequence; Na and K elements sit in an alkali metal layer and are arranged in a disordered subsequence. The cathode material of this present invention exhibits excellent electrochemical performance with a high specific capacity of 150 mAhg?1 at a high cut-off charge voltage of 4.3V, and the capacity retention of this pouch cell does not decay after 200 cycles.Type: ApplicationFiled: January 22, 2024Publication date: February 27, 2025Inventors: Fujun Li, Suning Gao, Tong Zhang, Xiangshuai Wei, Wei Hu
-
Patent number: 12144841Abstract: The present invention discloses Fuke Qianjin Capsules and a quality control method therefor. The capsules are made of Radix et caulis flemingiae, Caulis mahoniae, Herba andrographis, Zanthoxylum dissitum Hemsl., Caulis spatholobi, Radix angelicae sinensis, Radix codonopsis, and Radix rosa laevigata as raw materials. Each of the Fuke Qianjin Capsules contains not less than 2.0 mg of Z-ligustilide, and a total amount of andrographolide and dehydroandrographolide is not less than 1.9 mg. A new standard for controlling quality of the Fuke Qianjin Capsules has been established through an analysis of chemical ingredients in the Fuke Qianjin Capsules. This standard adds a variety of core ingredient content to the existing pharmacopoeia standards. According to the Fuke Qianjin Capsules made in this range, the consistency of effects between different batches is more stable. Moreover, the more the types of core ingredients are limited, the more stable the consistency of the drug effect.Type: GrantFiled: January 14, 2020Date of Patent: November 19, 2024Assignee: QIANJIN PHARMACEUTICAL CO., LTD.Inventors: Shun Jian, Yun Gong, Peng Zhang, Fujun Li, Yonggen Ling, Juanjuan He, Kanghua Wang, Xiuwei Yang
-
Publication number: 20240154113Abstract: A sodium-ion pouch cell belongs to the technical field of new energy materials and devices. The pouch cell and comprises a cathode piece, a diaphragm, a presodiated anode piece, an electrolyte, a tab and an aluminum plastic film package, and is obtained by sequentially laminating 1 to 30 cathode pieces and 2 to 31 presodiated anode pieces in a Z-shaped manner, adding the electrolyte and packaging, the sodium-ion pouch cell is characterized in that: the cathode piece contains an O3 layered oxide cathode material, a chemical formula is NaaNibZncFedMneTi(1-b-c-d-e)O2, 0.8?a?1, 0.2<b?0.5, 0<c?0.1, 0<d?0.2, 0.2<e?0.5, the presodiated anode piece contains a hard carbon anode material, and a double-sided density of the cathode piece is 28 mg/cm2 to 33 mg/cm2; and a double-sided density of the anode piece is 14 mg/cm2 to 16 mg/cm2, and a battery capacity is 0.1 Ah to 10 Ah.Type: ApplicationFiled: October 31, 2023Publication date: May 9, 2024Inventors: Fujun LI, Tong ZHANG, Suning GAO, Hengyi FANG, Meng REN, Jun CHEN
-
Publication number: 20220323525Abstract: The present invention discloses Fuke Qianjin Tablets and a quality control method therefor. The Fuke Qianjin Tablets are made of Radix Et Caulis Flemingiae, Caulis Mahoniae, Herba Andrographis, Zanthoxylum dissitum Hemsl., Caulis Spatholobi, Radix Angelicae Sinensis, Radix Codonopsis, and Radix Rosa Laevigata as raw materials. Each of the Fuke Qianjin Tablets contains not less than 0.008 mg of the genistin, not less than 0.7 mg of the Z-ligustilide, and the total amount of the andrographolide and the dehydroandrographolide is not less than 1.1 mg.Type: ApplicationFiled: January 14, 2020Publication date: October 13, 2022Applicant: QIANJIN PHARMACEUTICAL CO., LTD.Inventors: Duanyu JIANG, Peng ZHANG, Yun GONG, Fujun LI, Yingshuai ZHANG, Lu BAI, Wei ZHAO, Kanghua WANG, Xiuwei YANG
-
Publication number: 20220143125Abstract: The present invention discloses Fuke Qianjin Capsules and a quality control method therefor. The capsules are made of Radix Et Caulis Flemingiae, Caulis Mahoniae, Herba Andrographis, Zanthoxylum dissitum Hemsl., Caulis Spatholobi, Radix Angelicae Sinensis, Radix Codonopsis, and Radix Rosa Laevigata as raw materials. Each of the Fuke Qianjin Capsules contains not less than 2.0 mg of Z-ligustilide, and a total amount of andrographolide and dehydroandrographolide is not less than 1.9 mg. A new standard for controlling quality of the Fuke Qianjin Capsules has been established through an analysis of chemical ingredients in the Fuke Qianjin Capsules. This standard adds a variety of core ingredient content to the existing pharmacopoeia standards. According to the Fuke Qianjin Capsules made in this range, the consistency of effects between different batches is more stable. Moreover, the more the types of core ingredients are limited, the more stable the consistency of the drug effect.Type: ApplicationFiled: January 14, 2020Publication date: May 12, 2022Applicant: QIANJIN PHARMACEUTICAL CO., LTD.Inventors: Shun JIAN, Yun GONG, Peng ZHANG, Fujun LI, Yonggen LING, Juanjuan HE, Kanghua WANG, Xiuwei YANG
-
Patent number: 10329316Abstract: The present invention provides a phenylpropanoid compound and a preparation method and use thereof. The phenylpropanoid compound has a structural formula shown as formula (I), and the pharmaceutically acceptable salt has a structural formula shown as formula (II), formula (III), formula (IV), or formula (V). The phenylpropanoid compound and the pharmaceutically acceptable salt thereof have an effect on inhibiting a content of an inflammatory cytokine NO and an expression of an inflammatory cytokine TNF-?, have an effect on inhibiting a hydroxyl radical (—OH), thereby have anti-inflammatory and antioxidant activities, and has a good application prospect in preparing of a medicine for treating an inflammatory disease related to the above factors, such as cervicitis, endometritis, pelvic inflammatory disease, mastitis, sphagitis and/or arthritis.Type: GrantFiled: September 17, 2018Date of Patent: June 25, 2019Assignee: QIANJIN PHARMACEUTICAL CO., LTD.Inventors: Peng Zhang, Kaifeng Peng, Yun Gong, Fujun Li, Nifu Liu, Bohou Xia, Limei Lin
-
Publication number: 20190016744Abstract: The present invention provides a phenylpropanoid compound and a preparation method and use thereof. The phenylpropanoid compound has a structural formula shown as formula (I), and the pharmaceutically acceptable salt has a structural formula shown as formula (II), formula (III), formula (IV), or formula (V). The phenylpropanoid compound and the pharmaceutically acceptable salt thereof have an effect on inhibiting a content of an inflammatory cytokine NO and an expression of an inflammatory cytokine TNF-?, have an effect on inhibiting a hydroxyl radical (—OH), thereby have anti-inflammatory and antioxidant activities, and has a good application prospect in preparing of a medicine for treating an inflammatory disease related to the above factors, such as cervicitis, endometritis, pelvic inflammatory disease, mastitis, sphagitis and/or arthritis.Type: ApplicationFiled: September 17, 2018Publication date: January 17, 2019Applicant: QIANJIN PHARMACEUTICAL CO., LTD.Inventors: Peng Zhang, Kaifeng Peng, Yun Gong, Fujun Li, Nifu Liu, Bohou Xia, Limei Lin
-
Publication number: 20170098861Abstract: An electrolytic solution system for lithium secondary batteries. Provided is a lithium secondary battery electrolytic solution containing a nonaqueous solvent and a lithium salt. The nonaqueous solvent is mixed at an amount of not more than 3 mol with respect to 1 mol of the lithium salt.Type: ApplicationFiled: October 27, 2016Publication date: April 6, 2017Applicant: THE UNIVERSITY OF TOKYOInventors: Yuki YAMADA, Atsuo YAMADA, Makoto YAEGASHI, Haosheu ZHOU, Fujun LI
-
Patent number: 9614252Abstract: A new electrolytic solution system for lithium secondary batteries. Provided is a lithium secondary battery electrolytic solution containing a nonaqueous solvent and a lithium salt. The nonaqueous solvent is mixed at an amount of not more than 3 mol with respect to 1 mol of the lithium salt.Type: GrantFiled: March 25, 2013Date of Patent: April 4, 2017Assignee: THE UNIVERSITY OF TOKYOInventors: Yuki Yamada, Atsuo Yamada, Makoto Yaegashi, Haosheu Zhou, Fujun Li
-
Publication number: 20150050563Abstract: A new electrolytic solution system for lithium secondary batteries. Provided is a lithium secondary battery electrolytic solution containing a nonaqueous solvent and a lithium salt. The nonaqueous solvent is mixed at an amount of not more than 3 mol with respect to 1 mol of the lithium salt.Type: ApplicationFiled: March 25, 2013Publication date: February 19, 2015Applicant: THE UNIVERSITY OF TOKYOInventors: Yuki Yamada, Atsuo Yamada, Makoto Yaegashi, Haosheu Zhou, Fujun Li
-
Patent number: 8712338Abstract: The present invention discloses a method and system for implementing power detection, wherein said method includes: extracting basic information of a destination base station from a detection request, obtaining configuration information of said destination base station from a database according to the basic information, and searching available signal transmission links and power collection points of said destination base station according to the configuration information; carrying out power collection, and analyzing power values of each available power collection point on the available signal transmission link, and updating the power values of corresponding power collection points. With the present invention, power detection can be carried out on the device from a perspective of the system, and the maintainability and operability are improved.Type: GrantFiled: May 17, 2010Date of Patent: April 29, 2014Assignee: ZTE CorporationInventors: Dong Liu, Junfeng Xu, Fujun Li
-
Publication number: 20120231748Abstract: The present invention discloses a method and system for implementing power detection, wherein said method includes: extracting basic information of a destination base station from a detection request, obtaining configuration information of said destination base station from a database according to the basic information, and searching available signal transmission links and power collection points of said destination base station according to the configuration information; carrying out power collection, and analyzing power values of each available power collection point on the available signal transmission link, and updating the power values of corresponding power collection points. With the present invention, power detection can be carried out on the device from a perspective of the system, and the maintainability and operability are improved.Type: ApplicationFiled: May 17, 2010Publication date: September 13, 2012Applicant: ZTE CORPORATIONInventors: Dong Liu, Junfeng Xu, Fujun Li
-
Publication number: 20090218708Abstract: The present invention provides a method for preparing supersaturated aqueous solutions of micelles of compounds in which the solubility in water is less than the critical micelle concentration. The solutions can be process to prepare solid micelles which have advantageous properties for drug delivery.Type: ApplicationFiled: February 20, 2009Publication date: September 3, 2009Inventors: Lawrence Emerson Fisher, Shridhar Hegde, Jane Kuo, Dimitrios Stefanidis, Fujun Li